Written by In the late 1960s, three Weizmann Institute of Science researchers developed several protein-like molecules, called copolymers, that they believed would produce a disease similar to multiple sclerosis in laboratory animals. The scientists—Prof. Michael Sela, Prof. Ruth Arnon and Dr. Dvora Teitelbaum—were surprised to discover that, instead of causing the disease, the copolymers cured it; one of these molecules became the widely-used drug Copaxone.
Medical Xpress – latest medical and health news stories